CUDC-305, a novel synthetic HSP90 inhibitor with unique pharmacologic properties for cancer therapy (Q39840705)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
CUDC-305, a novel synthetic HSP90 inhibitor with unique pharmacologic properties for cancer therapy
scientific article

    Statements

    title
    CUDC-305, a novel synthetic HSP90 inhibitor with unique pharmacologic properties for cancer therapy (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    19509149
    retrieved
    15 September 2017
    author name string
    Rudi Bao
    series ordinal
    1
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    19509149
    retrieved
    15 September 2017
    Cheng-Jung Lai
    series ordinal
    2
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    19509149
    retrieved
    15 September 2017
    Dagong Wang
    series ordinal
    4
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    19509149
    retrieved
    15 September 2017
    Ling Yin
    series ordinal
    5
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    19509149
    retrieved
    15 September 2017
    Brian Zifcak
    series ordinal
    6
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    19509149
    retrieved
    15 September 2017
    Ruzanna Atoyan
    series ordinal
    7
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    19509149
    retrieved
    15 September 2017
    Jing Wang
    series ordinal
    8
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    19509149
    retrieved
    15 September 2017
    Maria Samson
    series ordinal
    9
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    19509149
    retrieved
    15 September 2017
    Jeffrey Forrester
    series ordinal
    10
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    19509149
    retrieved
    15 September 2017
    Steven DellaRocca
    series ordinal
    11
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    19509149
    retrieved
    15 September 2017
    Guang-Xin Xu
    series ordinal
    12
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    19509149
    retrieved
    15 September 2017
    Xu Tao
    series ordinal
    13
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    19509149
    retrieved
    15 September 2017
    Hai-Xiao Zhai
    series ordinal
    14
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    19509149
    retrieved
    15 September 2017
    Xiong Cai
    series ordinal
    15
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    19509149
    retrieved
    15 September 2017
    Changgeng Qian
    series ordinal
    16
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    19509149
    retrieved
    15 September 2017
    publication date
    9 June 2009
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    19509149
    retrieved
    15 September 2017
    page(s)
    4046-4057
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    19509149
    retrieved
    15 September 2017

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q39840705&oldid=2091309414"